Keyphrases
Oral Anticoagulant Therapy
100%
Direct Oral Anticoagulants
100%
Antiseizure Medication
100%
Anticoagulant Medications
100%
Rifampicin
22%
Cytochrome P450 (CYP450)
22%
Anticoagulant Concentration
22%
P-glycoprotein (P-gp)
16%
Peak Concentration
16%
Plasma Concentration
11%
Inducer
11%
Valproic Acid
11%
Treatment Failure
11%
Levetiracetam
11%
Concentration Monitoring
11%
Enzyme-inducing Anti-seizure Medication
11%
Absorption Mechanism
5%
Pharmacokinetics
5%
Metabolism
5%
Comparative Analysis
5%
Plasma Exposure
5%
Pharmacokinetic Drug Interactions
5%
Thrombotic Events
5%
Ischemic Events
5%
Vitamin K Antagonists
5%
Apixaban
5%
Rivaroxaban
5%
Exposure Area
5%
Oral Enzymes
5%
Specific Absorption Rate
5%
Concomitant Use
5%
Elimination Method
5%
Plasma Effect
5%
European Society of Cardiology
5%
Glycoprotein Transport
5%
Agricultural and Biological Sciences
Cytochrome P450
100%
Rifampicin
100%
P-Glycoprotein
75%
Blood Plasma
75%
Pharmacokinetics
50%
Europeans
25%
Vitamin K Antagonist
25%
Rivaroxaban
25%
Neuroscience
Antithrombotic
100%
Antiseizure Medication
100%
Cytochrome P450
22%
Rifampicin
22%
ABC Transporter Subfamily B
16%
Blood Plasma
16%
Valproic Acid
11%
Levetiracetam
11%
Pharmacokinetics
11%
Metabolic Pathway
5%
Glycoprotein
5%
Rivaroxaban
5%
Apixaban
5%
Vitamin K Antagonist
5%
Pharmacology, Toxicology and Pharmaceutical Science
Direct Oral Anticoagulant
100%
Cytochrome P450
22%
Rifampicin
22%
P-Glycoprotein
16%
Sodium Valproate
11%
Levetiracetam
11%
Pharmacokinetics
11%
Elimination
5%
Glycoprotein
5%
Drug Interaction
5%
Rivaroxaban
5%
Antivitamin K
5%
Apixaban
5%